ATLANTA-Officials at the Centers for Disease Control and Prevention (CDC) are reporting serious side effects for a common HIV medication.
Nevirapine, marketed by Ohio based Roxane Laboratories under the name Viramune, is often prescribed after HIV exposure. Theoretically it works more quickly than other AIDS drugs and is recommended for preventing AIDS transmission from infected mothers to their babies.
At least 22 people have suffered serious side effects, including liver failure, from taking the drug. Nevirapine is intended to prevent HIV infection after accidental exposure to the virus. The CDC reports that most of these people are healthcare workers who were exposed to HIV in the workplace.
The investigation began after a 43-year-old female healthcare worker who took nevirapine after a needlestick incident required a liver transplant. In a second incidence, a 38-year-old male physician who had mucous membrane exposure was hospitalized with hepatitis after taking nevirapine.
Information from www.washingtonpost.com
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.